AGER and early-onset autosomal dominant Alzheimer disease: As activation of RAGE accelerates pathological progression of diabetes or Alzheimer's disease, therapeutic treatments to attenuate activation of RAGE have been suggested [24] and experimented in animal disease or inflammation models [8], [25], [26], [27].